Regencell Bioscience Holdings Limited Stock
Equities
RGC
KYG7487R1002
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.21 USD | +0.04% | -6.29% | -50.38% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 300M |
---|---|---|---|---|---|
Net income 2022 | -7M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 15.65M | Net cash position 2023 | 11.1M | EV / Sales 2023 | - |
P/E ratio 2022 |
-59.5
x | P/E ratio 2023 |
-51.1
x | Employees | 12 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.24% |
1 day | +0.04% | ||
1 week | -6.29% | ||
Current month | -1.14% | ||
1 month | -0.19% | ||
3 months | -34.88% | ||
6 months | -60.55% | ||
Current year | -50.38% |
Managers | Title | Age | Since |
---|---|---|---|
Wai Hong Chung
COO | Chief Operating Officer | 46 | - |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
Yat-Pui Au
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wing Yan Lo
BRD | Director/Board Member | 63 | 21-12-12 |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
- | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.21 | +0.04% | 7,059 |
24-05-15 | 5.208 | +2.53% | 131 |
24-05-14 | 5.079 | -7.65% | 848 |
24-05-13 | 5.5 | -1.08% | 1,242 |
Delayed Quote Nasdaq, May 17, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-50.38% | 67.8M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- RGC Stock